Activation of ProMMP-9 by a plasmin/MMP3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 372-387

  Hahn Dantona, Elizabeth ^a   Ramos DeSimone, Noemi ^a   Sipley, John ^a   Nagase, Hideaki ^b   French, Deborah L ^c   Quigley, James P ^a,d  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME PRECURSOR; GELATINASE B; MONOCLONAL ANTIBODY; PLASMIN; PLASMINOGEN ACTIVATOR; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PHENOTYPE; TUMOR CELL;

ANIMALIA;

EID: 0032854658     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07696.x     Document Type: Conference Paper

References (42)

1. 1. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91: 439-442.
2. 2. Watson, S.A., T.M. Morris, G. Robinson, M.J. Crimmin, P.D. Brown & J.D. Hardcastle. 1995. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res. 55: 3629-3633.
3. 3. Ray, J.M. & W.G. Stetler-Stevenson. 1994. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7: 2062-2072.
4. 4. Wojtowicz-Praga S., J. Torri, M. Johnson, V. Steen, J. Marshall, E. Ness, R. Dickson, M. Sale, H.S. Rasmussen, T.A. Chiodo & M.J. Hawkins. 1998. Phase 1 trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. J. Clin. Oncol. 16: 2150-2156
5. 5. Springman, E.B., E.L. Angleton, H. Birkedal-Hansen & H.E. VanWart. 1990. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc. Natl. Acad. Sci. USA 87: 364-368.
6. 6. Pei, D. & S. Weiss. 1995. Furin-dependent intracellular activation of the human Stromelysin-3 zymogen. Nature 375: 244-257.
7. 7. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shingawa, E. Yamamoto & M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
8. 8. Strongin, A.Y., I. Collier, G. Bannikov, B.L. Marmer, G.A. Grant & G.I. Goldberg. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270: 5331-5338.
9. 9. He, C., S.M. Wilhelm, A.P. Pentland, B.L. Marmer, G.A. Grant, A.Z. Eisen & G.I. Goldberg. 1989. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA 86: 2632-2636.
10. 10. Ogata, Y., Y. Itoh & H. Nagase. 1995. Steps involved in activation of the promatrix rnetalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270: 18506-18511.
11. 11. Ramos-DeSimone, N., E. Hahn-Dantona, J. Sipley, H. Nagase, D.L. French & J.P. Quigley. 1999. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem. 274: 13066-13076.
12. 12. Nagase, H., J.J. Enghild, K. Suzuki & G. Salvensen. 1990. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29: 5783-5789.
13. 13. Birkedal-Hansen, H., W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo & J.A. Engler. 1993. Matrix metalloproteinases: a review. Critical Rev. Oral Biol. Med. 4: 197-250.
14. 14. Kolkhorst V., J. Sturzebecher & B. Wiederanders. 1998. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile. J. Cancer Res. Clin. Oncol. 124: 598-606.
15. 15. Goldberg G.I., B.L. Marmer, G.A. Grant, A.Z. Eisen, S. Wilhelm & C.S. He. 1989. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 21: 8207-8211.
16. 16. Howard, E.W. & M. Banda. 1991. Binding of tissue inhibitor of metalloproteinases 2 to two distinct binding sites on human 72-kDa gelatinase. J. Biol. Chem. 266: 17972-17977.
17. 17. Goldberg G.I., A. Strongin, I.E. Collier, L.T. Genrich & B.L. Marmer. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 7: 4583-4591.
18. 18. Brown, P.D., A.T. Levy, I. Margulies, L.A. Liotta & W.G. Stetler-Stevenson. 1990. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50: 6184-6191.
19. 19. Ward, R.V., S.J. Atkinson, P.M. Slocombe, A.J. Docherty, J.J. Reynolds & G. Murphy. 1991. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochem. Biophys. Acta 1079: 242-246.
20. 20. Moll, U.M., G. Youngleib, K. Rosinski & J.P. Quigley. 1990. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50: 6162-6170.
21. 21. Unemori, E., M.S. Hibbs & E.P. Armento. 1991. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88: 1656-1662.
22. 22. Kondapaka, S.B., R. Fridman & K.B. Reddy. 1997. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer 70: 722-726.
23. 23. Okada, Y., K. Naka, K. Kawamura, I. Nakanishi, M. Fujimoto, H. Sato & M. Seiki. 1995. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72: 311-322.
24. 24. Hibbs, M.S., K.A. Hasty, J.M. Seyer, A.H. Kang & C. Mainardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260: 2493-2500.
25. 25. Heppner, K.J., L.M. Matrisian, R.A. Jensen & W.H. Rogers. 1996. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149: 273-282.
26. 26. Stetler-Stevenson, W.G., S. Aznavoorian & L.A. Liotta. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-573.
27. 27. MacDougall, J.R. & L.M. Matrisian. 1995. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast. Rev. 14:351-362.
28. 28. Mignatti, P. & D.B. Rifkin. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195.
29. 29. Himelstein, B.P., R. Conte-Soler, E.J. Bernhard, D.W. Dilks & R.J. Muschel. 1994. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metast. 14: 246-258.
30. 30. Bernhard, E.J., S.B. Gruber & R.J. Muschel. 1994. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA. 91: 4293-4297.
31. 31. Hua, J. & R.J. Muschel. 1996. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res. 56: 5279-5284.
32. 32. Kim, J., W. Yu, K. Kovalski & L. Ossowski. 1998. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353-362.
33. 33. Suzuki, K., C. Kan, W. Hung, M.R. Gehring, K. Brew & H. Nagase. 1998. Expression of human pro-matrix metalloproteinase 3 that lacks the N-terminal 34 residues in Escherichia coli: autoactivation and interaction with tissue inhibitor of metalloproteinase 1 (TIMP-1). J. Biol. Chem. 379: 185-191.
34. 34. Ramos-DeSimone, N, U.M. Moll, J.P. Quigley & D.L. French. 1993. Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody. Hybridoma 12: 349-363.
35. 35. Mallya, S.K., K.A. Mooktiar & H.E. VanWart. 1986. Accurate, quantitative assays for the hydrolysis of soluble type I, II, and III 3H-acetylated collagens by bacterial and tissue collagenases. Anal. Biochem. 158: 322-333.
36. 36. Aimes, R.T. & J.P. Quigley. 1997. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem. 270: 5872-5876.
37. 37. Nagase, H., J.J. Enghild, K. Suzuki & G. Salvensen. 1990. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry. 29: 5783-5789.
38. 38. Rudolph-Owen, L.A., D.L. Hulhoy, C.L. Wilson, J. Mudgett & L.M. Matrisian. 1997. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 138: 4902-4911.
39. 39. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior & Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
40. 40. Mazzieri, R., L. Masiero, L. Zanetta, S. Monea, M. Onisto, S. Garbisa & P, Mignatti. 1997. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16: 2319-2332.
41. 41. Knauper, V., B. Smith, C. Lopez-Otin & G. Murphy. 1997. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur. J. Biochem. 248: 369-373.
42. 42. Knauper, V., H. Will, C. Lopez-Otin, B. Smith, S.J. Atkinson, H. Stanton, R.M. Hembry & G. Murphy. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271: 17124-17131.